www.fdanews.com/articles/101869-chemokine-therapeutics-corp-withdraws-registration-statement
Chemokine Therapeutics Corp. Withdraws Registration Statement
December 5, 2007
Chemokine Therapeutics Corp., a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, announced that the company has withdrawn the registration statement relating to the public offering, announced on May 30, 2007, due to market conditions.
BioSpace
BioSpace